| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
4e-09 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
2e-06 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
1e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0001 |